BTK is renowned for its critical role in BCR signaling and was originally identified as the gene defective in X-linked agammaglobulinemia (XLA) patients (Tsukada et al., 1993; Vetrie et al., 1993). This evidence concerns the gene BCR and Bruton-type agammaglobulinemia.